Wednesday, July 08, 2020 2:49:41 PM
https://fintel.io/doc/sec-tnxp-8k-tonix-pharmaceuticals-holding-2020-july-07-18450
Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Security TNXP / Tonix Pharmaceuticals Holding Corp. (890260201)
Form Type 8-K
File Date 2020-07-07
yesw
Tonix Pharmaceuticals Plans Massachusetts R&D Facility to Accelerate
Clinical Development of Vaccines and Protein-Based Therapeutics
Recent TNXP News
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
